Skip to main content

Table 3 OAS values (mean ± SD) at pre-treatment (day 0), day 14 and day 28 for each treatment group

From: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis

 

Time

Firocoxib

PCSO-524

Combination

P-value*

OAS

Day 0 (point)

5.42 ± 2.70 a

6.59 ± 2.99 a

5.43 ± 2.28 a

0.1559

Day 14 (point)

6.13 ± 2.44 a

6.59 ± 2.96 a

5.39 ± 2.57 a

 

Day 28 (point)

5.79 ± 2.60 a

6.93 ± 1.94 a

5.71 ± 2.66 a

 
  1. SD standard deviation
  2. ap-value < 0.05 from Tukey’s Studentized Range within each treatment
  3. *p-value from repeated measurement analysis for 3 treatment
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us